208 related articles for article (PubMed ID: 1806546)
1. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
Warrington S; Debbas N; Farthing M; Horton M; Umile A
Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
[TBL] [Abstract][Full Text] [Related]
2. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
Warrington S
Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
[TBL] [Abstract][Full Text] [Related]
3. Renal and gastrointestinal tolerability of lornoxicam, and effects on haemostasis and hepatic microsomal oxidation.
Warrington SJ; Lewis Y; Dawnay A; Johnston A; Kovacs IB; Lamb E; Ravic M
Postgrad Med J; 1990; 66 Suppl 4():S35-40. PubMed ID: 2284219
[TBL] [Abstract][Full Text] [Related]
4. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
[TBL] [Abstract][Full Text] [Related]
5. Lornoxicam, indomethacin and placebo: comparison of effects on faecal blood loss and upper gastrointestinal endoscopic appearances in healthy men.
Warrington SJ; Debbas NM; Farthing M; Horton M; Johnston A; Thillainayagam A; Turner P; Ferber H
Postgrad Med J; 1990 Aug; 66(778):622-6. PubMed ID: 2217030
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain.
Dolci G; Ripari M; Pacifici L; Umile A
Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875
[TBL] [Abstract][Full Text] [Related]
7. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
[TBL] [Abstract][Full Text] [Related]
8. Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.
Santucci L; Fiorucci S; Chiucchiù S; Sicilia A; Bufalino L; Morelli A
Dig Dis Sci; 1992 Dec; 37(12):1825-32. PubMed ID: 1473431
[TBL] [Abstract][Full Text] [Related]
9. [Comparative endoscopic study of gastroduodenal tolerance of piroxicam-beta-cyclodextrin vs piroxicam].
Müller P; Simon B
Z Rheumatol; 1997; 56(2):76-9. PubMed ID: 9235813
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of ranitidine in the stomach and duodenum against piroxicam. An endoscopy controlled double-blind study].
Müller P; Simon B
Arzneimittelforschung; 1992 Dec; 42(12):1492-4. PubMed ID: 1288514
[TBL] [Abstract][Full Text] [Related]
11. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
Reginster JY; Franchimont P
Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
[TBL] [Abstract][Full Text] [Related]
12. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
Lister RE; Acerbi D; Cadel S
Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
[TBL] [Abstract][Full Text] [Related]
13. A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers.
Patoia L; Santucci L; Furno P; Dionisi MS; Dell'Orso S; Romagnoli M; Sattarinia A; Marini MG
Br J Rheumatol; 1996 Apr; 35 Suppl 1():61-7. PubMed ID: 8630640
[TBL] [Abstract][Full Text] [Related]
14. [High-dose ranitidine protects stomach and duodenum completely against piroxicam. An endoscopic double-blind pilot study].
Müller P; Leucht U; Simon B
Z Gastroenterol; 1992 Dec; 30(12):851-3. PubMed ID: 1481550
[TBL] [Abstract][Full Text] [Related]
15. The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.
Lanza F; Sahba B; Schwartz H; Winograd S; Torosis J; Quan H; Reyes R; Musliner T; Daifotis A; Leung A
Am J Gastroenterol; 2002 Jan; 97(1):58-64. PubMed ID: 11808969
[TBL] [Abstract][Full Text] [Related]
16. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.
Stoltz RR; Harris SI; Kuss ME; LeComte D; Talwalker S; Dhadda S; Hubbard RC
Am J Gastroenterol; 2002 Jan; 97(1):65-71. PubMed ID: 11808971
[TBL] [Abstract][Full Text] [Related]
17. [Endoscopic, histologic and morphometric evaluation of the gastric mucosa in patients with osteoarthritis treated with piroxicam and zinc acexamate].
Guilarte López-Mañas J; Valenzuela Barranco M; Caballero Plasencia AM; Martín Ruiz JL
Gastroenterol Hepatol; 1998 May; 21(5):212-7. PubMed ID: 9644873
[TBL] [Abstract][Full Text] [Related]
18. Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain.
Chang ST; Chen LC; Chang CC; Chu HY; Tsai KC
J Clin Pharm Ther; 2008 Oct; 33(5):495-506. PubMed ID: 18834364
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic and endoscopic comparison of an oral and an experimental buccal piroxicam formulation.
Mueller BA; Rex DK; Figueroa N; Greene P; Brater DC
Pharmacotherapy; 1992; 12(2):93-7. PubMed ID: 1570233
[TBL] [Abstract][Full Text] [Related]
20. Comparative population pharmacokinetic-pharmacodynamic analysis for piroxicam-beta-cyclodextrin and piroxicam.
Wang D; Miller R; Zheng J; Hu C
J Clin Pharmacol; 2000 Nov; 40(11):1257-66. PubMed ID: 11075311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
